Scarica l'app Stockscreener
1.79
7.83%
0.13
Dopo l'orario di chiusura:
1.79
Precedente Chiudi:
$1.66
Aprire:
$1.72
Volume 24 ore:
519.89K
Relative Volume:
3.19
Capitalizzazione di mercato:
$31.01M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+0.56%
1M Prestazione:
-26.64%
6M Prestazione:
-57.98%
1 anno Prestazione:
-42.44%
Intervallo 1D:
$1.675
$1.80
Intervallo di 1 settimana:
$1.53
$1.8027
Portata 52W:
$0.95
$4.74
Mural Oncology Plc Stock (MURA) Company Profile
Nome
Mural Oncology Plc
Settore
Industria
Telefono
353 1 905 8020
Indirizzo
10 EARLSFORT TERRACE, DUBLIN 2
Confronta MURA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MURA
Mural Oncology Plc
|
1.79 | 28.76M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2024-06-28 | Iniziato | Rodman & Renshaw | Buy |
| 2024-04-04 | Iniziato | Morgan Stanley | Overweight |
Mural Oncology Plc Borsa (MURA) Ultime notizie
Form 8.3Mural Oncology plc - Business Wire
Citadel Group discloses 1.17% stake in Mural Oncology - Investing.com India
Citadel Group discloses 1.17% stake in Mural Oncology By Investing.com - Investing.com South Africa
Candlestick Reversal Detected on Mural Oncology plc’s ChartAlpha Driven Watchlist With Alerts Published - metal.it
Citadel Group discloses 1.23% stake in Mural Oncology By Investing.com - Investing.com Australia
Citadel Group discloses 1.23% stake in Mural Oncology - Investing.com
Mural Oncology Q2 Loss Surges 49%, Ending All R&D Activities and Exploring Strategic Alternatives. - AInvest
Mural Oncology (MURA) Q2 Loss Widens 49% - The Motley Fool
Mural Oncology announces second quarter financial results and provides business update - MarketScreener
Mural Oncology plc SEC 10-Q Report - TradingView
Mural Oncology Slashes Workforce by 90%, Explores Sale with $77M Cash Runway - Stock Titan
How strong is Mural Oncology plc company’s balance sheetUnlock market-leading stock analysis - jammulinksnews.com
What are analysts’ price targets for Mural Oncology plc in the next 12 monthsPowerful market insights - Jammu Links News
Is it the right time to buy Mural Oncology plc stockStrongest growth potential - Jammu Links News
What analysts say about Mural Oncology plc stockNavigate the market with precision tools - Jammu Links News
What institutional investors are buying Mural Oncology plc stockGet real-time alerts on top stocks - Jammu Links News
What makes Mural Oncology plc stock price move sharplyHigh-profit capital plays - Jammu Links News
Mural Oncology plc Stock Analysis and ForecastDiscover breakthrough trading strategies - Jammu Links News
How volatile is Mural Oncology plc stock compared to the marketEarnings Report Alerts To Watch Now - Jammu Links News
Mural Oncology plc Forms Bullish Flag — Upside AheadDaily Stock Market Swing Alerts Highlight Key Movers - beatles.ru
Is Mural Oncology plc the Top Chart Pick This WeekAlpha Focused Technical Trade Signals Gain Attention - metal.it
Can Mural Oncology plc Regain Lost Ground This QuarterTechnical Stock Breakout Predictions Signal Entry Points - metal.it
Support Zone Holds Steady for Mural Oncology plc After DipShort Term Trading Opportunity Watch Sees Shift - metal.it
Disclosure of Opening Position in Mural Oncology plc by The Vanguard Group, Inc. - AInvest
Mural Oncology plc Price Targets Raised After ReboundTrade Timing Strategy With Technical Data Explained - metal.it
Mural Oncology plc Attempts Reversal From Key SupportCommunity Verified Stock Suggestions Drive Volume - metal.it
Watch for Trend Continuation in Mural Oncology plc Next WeekStock Selection With High Accuracy Based on Models - metal.it
Real Time Chart Alerts Flash Bullish on Mural Oncology plcCapital Preserving Trade Plan Templates Shared - metal.it
Should I hold or sell Mural Oncology plc stock in 2025Unlock your portfolio’s full growth potential - Jammu Links News
Mural Oncology plc Pullback Analyzed — Is It Time to ExitOversold Bounce Stock Play Ideas Gain Attention - metal.it
How Resilient Is Mural Oncology plc Stock During Economic DownturnsTop Performing Low Risk Stocks - metal.it
Does Mural Oncology plc stock perform well during market downturnsFree Predictions - jammulinksnews.com
Is Mural Oncology plc a good long term investmentUnmatched market gains - PrintWeekIndia
Will Mural Oncology plc stock benefit from interest rate changesBreakthrough profit margins - Jammu Links News
Is Mural Oncology plc stock a growth or value playBreakneck growth rates - jammulinksnews.com
Mural Oncology Plc Azioni (MURA) Dati Finanziari
Non sono disponibili dati finanziari per Mural Oncology Plc (MURA). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
1.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):